Newell Brands falls following Q4 earnings report Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Xeris Pharmaceuticals (XERS) up 22% after announcing that the European Commission has approved Ogluo injection for the treatment of severe hypoglycaemia in adults, adolescents and children aged two years and over with diabetes mellitus
- NantKwest (NK) up 10% after announcing that they have received FDA authorization to expand Phase I testing of a bivalent hAd5 T-cell COVID-19 vaccine
- Fusion Acquisition (FUSE) up 5% after MoneyLion and the company have entered into a definitive agreement which would result in MoneyLion becoming a publicly listed company
- Inovio Pharmaceuticals (INO) up 20% after Oppenheimer analyst Hartaj Singh initiated coverage of shares with an Outperform rating and $35 price target
UP AFTER EARNINGS -
- Disney (DIS) up 1%
- HubSpot (HUBS) up 19%
DOWN AFTER EARNINGS -
- Newell Brands (NWL) down 4%
- Limelight Networks (LLNW) down 23%
LOWER -
- Virgin Galactic (SPCE) down 10% after stating in a tweet that the company has decided to allow more time for technical checks before a flight test
- Protalix (PLX) down 17% after 7.6M share spot secondary priced at $4.60
- Codiak (CDAK) down 9% after 2.75M share secondary priced at $21.00
- SOS Limited (SOS) down 14% after raising $110M in a registered direct offering
Symbols:
XERS NK INO DIS HUBS - $431.81 /
+7.985 (+1.88%)
NWL LLNW PLX CDAK SPCE FUSE Keywords: Fly Intel, Wall Street, Top Stories, Stocks